Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Cloud computing In Pharmaceutical Market Growth From $15.07 Billion In 2026 To $27.6 Billion By 2030 At A CAGR Of 16.3%
The cloud computing in pharmaceutical market size has seen swift expansion over recent years. It is projected to expand from $12.93 billion in 2025 to $15.07 billion in 2026, registering a compound annual growth rate (CAGR) of 16.6%. Historically, this expansion was driven by several factors, including the heightened adoption of digital data management, a growing requirement for scalable information technology (IT) infrastructure, the increasing application of cloud services for clinical data storage, the broadening of pharmaceutical research and development (R&D) activities, and a greater emphasis on cost-efficient computing systems.
The cloud computing in pharmaceutical market is expected to show significant expansion over the next few years. It is forecast to grow to $27.60 billion in 2030 at a compound annual growth rate (CAGR) of 16.3%. This anticipated growth during the forecast period is driven by factors such as the increasing demand for AI-enabled drug discovery, a rising adoption of hybrid cloud models, an escalating shift towards digital pharmaceutical manufacturing, the expanded use of real-world data and analytics, and a growing requirement for secure cloud-based compliance systems. Major trends for the period include advancements in AI and machine learning platforms, developments in cloud-based clinical trial technologies, innovations in blockchain-enabled data security, ongoing research and development in automated pharmaceutical workflows, and advancements in big data analytics for drug development.
Get A Free Sample Report With In-Depth Market Insights:
Cloud computing In Pharmaceutical Market Industry Drivers: What’s Behind The Revenue Growth?
The escalating need for personalized medicine is anticipated to fuel the expansion of the cloud computing in pharmaceutical market moving forward. Personalized medicine represents a healthcare strategy focused on customizing treatments for individual patients, considering their unique genetic makeup, environmental influences, and lifestyle choices to enhance results and healthcare quality. The growing demand for personalized medicine stems from progress in genomic technologies, which facilitate the accurate detection of genetic differences and the development of customized therapies for individuals. Within the pharmaceutical sector, cloud computing bolsters personalized medicine by allowing for the scalable storage and analysis of vast amounts of patient, genomic, and clinical information. This technology contributes to greater treatment precision and quicker development times by facilitating sophisticated analytics, collaborative efforts in real-time, and data-centric drug discovery aligned with specific patient profiles. As an illustration, in February 2024, data from the US-based nonprofit organization, the Personalized Medicine Coalition (PMC), revealed that the U.S. Food and Drug Administration (FDA) sanctioned 26 novel personalized medicines in 2023, marking a considerable rise from the 12 approved in 2022. Consequently, the heightened demand for personalized medicine is propelling the expansion of the cloud computing in pharmaceutical market.
Cloud computing In Pharmaceutical Market Segment Breakdown: Which Categories Lead On Revenue?
The cloud computing in pharmaceutical market covered in this report is segmented –
1) By Service Model: Infrastructure As A Service (IaaS), Platform As A Service (PaaS), Software As A Service (SaaS)
2) By Deployment Type: Public Cloud, Private Cloud, Hybrid Cloud
3) By Technology Type: Artificial Intelligence (AI) And Machine Learning, Big Data Analytics, Internet Of Things (IoT), Blockchain, Data Backup And Disaster Recovery Solutions
4) By Application Area: Drug Discovery And Development, Clinical Trials Management, Manufacturing And Supply Chain, Regulatory Compliance, Pharmacovigilance
5) By End User: Pharmaceutical Companies, Biotechnology Firms, Research Organizations, Contract Research Organizations (CROs), Academic Institutions
Subsegments:
1) By Infrastructure As A Service: Virtual Machines, Storage Services, Networking Services, Backup Services, Disaster Recovery
2) By Platform As A Service: Application Hosting, Database Management, Development Tools, Middleware Services, Integration Services
3) By Software As A Service: Clinical Data Management Software, Regulatory Compliance Software, Supply Chain Management Software, Collaboration Tools, Analytics Software
#Cloud computing In Pharmaceutical Market Growth Trends: What’s Shaping The Future Outlook?
Major companies operating in the cloud computing in pharmaceutical market are concentrating on developing advanced platforms, such as unifying platforms, to strengthen data protection, ensure regulatory compliance, and boost operational efficiency across scientific software platforms. A unifying platform is defined as a singular, integrated system that combines multiple tools, functions, or services into one cohesive interface. For instance, in April 2024, Certara Inc., a US-based provider of model-informed drug development software, introduced Certara Cloud. This unifying platform integrates the company’s extensive array of scientific software solutions, enabling customers to access and manage their licensed products from discovery to submission using a single login ID, thereby improving user experience and accelerating time-to-insight for novel therapeutic programs. This cloud platform is designed to further unify its end-to-end scientific software ecosystem, incorporating centralized security and IT administration. By embedding centralized security controls within its cloud platform, Certara enhances data integrity, simplifies regulatory compliance, and supports secure collaboration throughout the drug development lifecycle, from early research through regulatory submission.
Cloud computing In Pharmaceutical Market Competitive Overview And Top Companies
Major companies operating in the cloud computing in pharmaceutical market are Amazon Web Services Inc., Google LLC, Microsoft Corporation, Alibaba Group Holding Ltd., Dell Technologies Inc., Tencent Holdings Ltd., Accenture plc, International Business Machines Corporation, Cisco Systems Inc., Oracle Corporation, Salesforce Inc., SAP SE, Hewlett Packard Enterprise Company, Capgemini SE, Cognizant Technology Solutions Corporation, DXC Technology Company, Akamai Technologies Inc., Snowflake Inc., CareCloud Inc., ClearDATA Networks Inc.
View The Full Cloud computing In Pharmaceutical Market Report:
Cloud computing In Pharmaceutical Market Top Region: Where Does Most Revenue Come From?
North America was the largest region in the cloud computing in pharmaceutical market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cloud computing in pharmaceutical market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.
